HighQC Human iPSC-Derived Skeletal Myocytes DMD Exon 44 Deletion

Description

HighQC Human iPSC-Derived Skeletal Myocytes DMD Exon 44 Deletion are human iPSC-derived skeletal myocytes generated from a human iPSC line originally derived from adult skin fibroblasts. These cryopreserved cells provide a defined in vitro model for Duchenne muscular dystrophy (DMD) research in skeletal muscle biology. The cells are produced through a directed differentiation protocol to support reproducible lineage-specific experimental systems. This line carries a deletion of exon 44 in the DMD gene, resulting in dystrophin deficiency relevant to Duchenne muscular dystrophy, without implying a fixed clinical phenotype. They retain skeletal muscle lineage characteristics relevant to myocyte research. Quality control testing includes sterility assessment and lineage characterization by protein expression and gene expression assays, where applicable. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.